Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
5.40
-0.10 (-1.82%)
Apr 25, 2025, 11:37 AM EDT - Market open
Precision BioSciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 85.9 | 116.68 | 189.58 | 143.66 | 89.8 | Upgrade
|
| Short-Term Investments | 0.41 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 86.31 | 116.68 | 189.58 | 143.66 | 89.8 | Upgrade
|
| Cash Growth | -26.02% | -38.45% | 31.96% | 59.98% | -50.36% | Upgrade
|
| Accounts Receivable | 1.7 | 0.9 | 0.72 | 0.49 | 10 | Upgrade
|
| Receivables | 1.7 | 12.8 | 0.72 | 0.49 | 10 | Upgrade
|
| Prepaid Expenses | 6.44 | 5.98 | 6.03 | 17.43 | 5.76 | Upgrade
|
| Other Current Assets | 0.54 | 0.91 | 2.78 | 0.17 | 0 | Upgrade
|
| Total Current Assets | 94.99 | 136.36 | 199.11 | 161.75 | 105.56 | Upgrade
|
| Property, Plant & Equipment | 10.18 | 14.6 | 13.78 | 29.33 | 41.5 | Upgrade
|
| Long-Term Investments | 3.21 | 3.21 | 4.75 | 6.84 | - | Upgrade
|
| Other Intangible Assets | 0.62 | 0.4 | 0.73 | 2.05 | 1.37 | Upgrade
|
| Other Long-Term Assets | 22.79 | 0.23 | 12.57 | 4.64 | 1.72 | Upgrade
|
| Total Assets | 136.39 | 159.78 | 238.17 | 211.5 | 150.16 | Upgrade
|
| Accounts Payable | 1.31 | 2.97 | 0.65 | 1.14 | 0.79 | Upgrade
|
| Accrued Expenses | 7.2 | 6.54 | 6.93 | 10.79 | 9.01 | Upgrade
|
| Short-Term Debt | - | 22.41 | - | - | - | Upgrade
|
| Current Portion of Leases | 1.32 | 1.13 | 1.68 | 1.82 | 1.93 | Upgrade
|
| Current Unearned Revenue | 2.96 | 12.04 | 46.19 | 21.24 | 30.24 | Upgrade
|
| Other Current Liabilities | 2.19 | 4.9 | 4.21 | 0.98 | 0.85 | Upgrade
|
| Total Current Liabilities | 14.98 | 49.99 | 59.66 | 35.98 | 42.83 | Upgrade
|
| Long-Term Debt | 22.32 | - | 22.22 | 2.48 | - | Upgrade
|
| Long-Term Leases | 6.4 | 7.72 | 1.06 | 4.81 | 8.59 | Upgrade
|
| Long-Term Unearned Revenue | 33.3 | 83.08 | 92.87 | 77.02 | 53.93 | Upgrade
|
| Other Long-Term Liabilities | 2.99 | 0.13 | 1.92 | 0.04 | 0.39 | Upgrade
|
| Total Liabilities | 80 | 140.92 | 177.74 | 120.33 | 105.73 | Upgrade
|
| Common Stock | 0 | 0 | 0 | - | - | Upgrade
|
| Additional Paid-In Capital | 539.81 | 509.44 | 489.7 | 408.8 | 331.45 | Upgrade
|
| Retained Earnings | -482.46 | -489.63 | -428.31 | -316.68 | -286.07 | Upgrade
|
| Treasury Stock | -0.95 | -0.95 | -0.95 | -0.95 | -0.95 | Upgrade
|
| Total Common Equity | 56.39 | 18.86 | 60.43 | 91.17 | 44.43 | Upgrade
|
| Shareholders' Equity | 56.39 | 18.86 | 60.43 | 91.17 | 44.43 | Upgrade
|
| Total Liabilities & Equity | 136.39 | 159.78 | 238.17 | 211.5 | 150.16 | Upgrade
|
| Total Debt | 30.05 | 31.27 | 24.96 | 9.11 | 10.52 | Upgrade
|
| Net Cash (Debt) | 56.27 | 85.41 | 164.62 | 134.55 | 79.28 | Upgrade
|
| Net Cash Growth | -34.12% | -48.12% | 22.35% | 69.72% | -56.17% | Upgrade
|
| Net Cash Per Share | 8.17 | 22.23 | 56.19 | 68.78 | 45.71 | Upgrade
|
| Filing Date Shares Outstanding | 10.48 | 6.92 | 3.71 | 2.03 | 1.9 | Upgrade
|
| Total Common Shares Outstanding | 8.2 | 4.16 | 3.7 | 2.03 | 1.76 | Upgrade
|
| Working Capital | 80.01 | 86.37 | 139.44 | 125.77 | 62.74 | Upgrade
|
| Book Value Per Share | 6.87 | 4.53 | 16.34 | 44.91 | 25.29 | Upgrade
|
| Tangible Book Value | 55.77 | 18.46 | 59.7 | 89.12 | 43.05 | Upgrade
|
| Tangible Book Value Per Share | 6.80 | 4.43 | 16.14 | 43.90 | 24.51 | Upgrade
|
| Machinery | 18.7 | 19.38 | 20.78 | 22.93 | 25.3 | Upgrade
|
| Construction In Progress | 0.01 | 0.07 | 0.52 | 3.04 | 1.89 | Upgrade
|
| Leasehold Improvements | 12.03 | 11.95 | 11.95 | 22.78 | 26.58 | Upgrade
|
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.